COMPANY PROFILE
provitro AG
AG (Stock Corporation)BerlinResearch and experimental development on biotechnology
REGISTERED SINCE
2001
25+ years registered
TRADE REGISTER
HRB 158413
Berlin (Charlottenburg)
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Small enterprise
- +49 30 450578358
- Visit website
- Email— Available in the full profile
Key questions answered
What does the company do?
Die Herstellung, Lagerung und der Vertrieb von Produkten sowie die Durchführung von Dienstleistungen für die biomedizinische Forschung und Entwicklung.
Original text from the German commercial register
Who leads it?
Oliver Bosnjak · Board Member
How large is it?
Small enterprise
How stable is it?
Stability assessment in the full profile
Business activity
Die provitro AG ist auf die Herstellung, Lagerung und den Vertrieb von Produkten sowie die Durchführung von Dienstleistungen für die biomedizinische Forschung und Entwicklung spezialisiert. Das Unternehmen bietet eine Vielzahl von Produkten an, darunter Vollblut, Stammzellen, Primärzellkulturen, Zellkulturreagenzien und umfassende Bioassay-Services. Die Zielgruppe umfasst Institutionen und Unternehmen aus den Bereichen biomedizinische Forschung und Entwicklung, insbesondere in den Branchen Biotechnologie, Naturwissenschaften, Ingenieurwissenschaften und Medizin, sowohl B2B als auch B2C. Ein wesentliches Merkmal der provitro AG ist die mehr als zehnjährige Erfahrung in der Produktion und der hohe Standard der ethischen Integrität in ihrer Geschäftspraxis.
Available in German only
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Small
Industry (WZ2008) (3)
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
- M74.90Other professional, scientific and technical activities n.e.c.
Business purpose
Die Herstellung, Lagerung und der Vertrieb von Produkten sowie die Durchführung von Dienstleistungen für die biomedizinische Forschung und Entwicklung.
Original text from the German commercial register
Address & Contact
Legal essentials
- Register entry
- HRB 158413 (Berlin (Charlottenburg))
- Legal form
- AG (Stock Corporation)
- Registered since
- 18 Oct 2001
- Share capital
- €350,000
- Representation rules
- Available in the full profile
Annual statements
- Balance sheet
- €927,318
- Year
- 2023
9 annual statements are on file for this company.
Annual financial statements (PDF)
The most recently published annual financial statements as a PDF, straight from the German company register.
Included in the free account's starter credit, then 10 Implicents, only if found.
Sign up free and downloadSignals
Four dimensions from hard data — age, financials, register events, compliance. The ratings themselves are in the full profile.
- Continuity1Available in the full profile
- Financials2Available in the full profile
- Management3Available in the full profile
- Legal status4Available in the full profile
Directors & officers
Executive board
Oliver Bosnjak
Board Member
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Companies with a similar profile
Location neighbours
GHC Global Health Care GmbH
Berlin · ⌂ same building
VMscope GmbH
Berlin · ⌂ same building
Charité Research Organisation GmbH
Berlin · ⌂ same building
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server at mcp.implisense.com — usable with ChatGPT, Claude and your own agents.
Plus opens every profile
Every company profile in full, without spending Implicents on it — plus wider search reach, unlimited lists and the enriched export.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- The full commercial register history — on every profile
- Full search reach instead of the first page of hits
- Enriched Excel export (Plus only)